ClinicalTrials.Veeva

Menu
C

Cabrini Health | Cabrini Hospital Malvern - Medical Oncology Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Carboplatin
Docetaxel
Gemcitabine
Vicadrostat
BI 690517
Androgen
Pralatrexate
HMBD-001
Atorvastatin Calcium
Cetuximab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 20 total trials
Locations recently updated

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyog...

Not yet enrolling
Wrist Disarticulation
Transradial Amputation
Device: Phantom X multielectrode EMG sensor array implant for upper limb prosthesis control

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinom...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

This is a phase 1b multi-center, open-label study of HMBD-001 in combination with docetaxel with or without cetuximab in participants with locally ad...

Enrolling
Advanced Head and Neck Squamous Cell Carcinoma
Cervical Squamous Cell Carcinoma
Drug: HMBD-001
Drug: Cetuximab

This is a phase 1b multi-center, open-label study of HMBD-001 with or without chemotherapy in participants with advanced solid tumors harboring NRG1...

Active, not recruiting
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Drug: Gemcitabine
Drug: Nab-paclitaxel

MYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety, tolerability, and define the RP2D of MT-302 in particip...

Enrolling
Epithelial Tumors, Malignant
Drug: MT-302 (A)

The primary purpose of this study is to evaluate the safety, pharmacokinetics,, and preliminary anti-tumor activity of TLN-121 as a single agent and...

Enrolling
Lymphoma
Lymphoma, Non Hodgkin
Drug: TLN-254
Drug: TLN-121

The WOMBAT study will test if BAT can prolong the time it takes for nmCRPC prostate cancer to become detectable in other areas of the body (metastati...

Enrolling
Prostate Cancer
Drug: Testosterone Enanthate

Trial sponsors

AbbVie logo
H
Boehringer Ingelheim logo
CStone Pharmaceuticals logo
G
Incyte logo
Karyopharm Therapeutics logo
M
Spectrum Pharmaceuticals logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems